Published in Mol Cell Biol on August 01, 2001
p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev (2004) 3.16
Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev Cell (2013) 1.78
p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior. Oncogene (2010) 1.64
p66Shc mediates anoikis through RhoA. J Cell Biol (2007) 1.08
Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting. Br J Pharmacol (2006) 1.04
Ras is required for the cyclic AMP-dependent activation of Rap1 via Epac2. Mol Cell Biol (2008) 1.03
Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells. Cell Death Differ (2016) 0.92
Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate. PLoS One (2010) 0.91
Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol Cell Biol (2002) 0.90
MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma. Am J Pathol (2012) 0.87
Acquisition of anoikis resistance through CD147 upregulation: A new mechanism underlying metastasis of hepatocellular carcinoma cells. Oncol Lett (2012) 0.86
A Rab10:RalA G protein cascade regulates insulin-stimulated glucose uptake in adipocytes. Mol Biol Cell (2014) 0.84
JNK-mediated phosphorylation of paxillin in adhesion assembly and tension-induced cell death by the adenovirus death factor E4orf4. J Biol Chem (2008) 0.84
AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells. PLoS One (2014) 0.83
The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development. Mol Biol Cell (2012) 0.81
N-cadherin mediates neuronal cell survival through Bim down-regulation. PLoS One (2012) 0.81
Ras inhibition induces insulin sensitivity and glucose uptake. PLoS One (2011) 0.81
Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition. J Mol Signal (2009) 0.80
Active contractility at E-cadherin junctions and its implications for cell extrusion in cancer. Cell Cycle (2015) 0.77
PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation. J Cell Mol Med (2014) 0.77
Mechanotransduction and anoikis: death and the homeless cell. Cell Cycle (2008) 0.77
Tumour-suppression function of KLF12 through regulation of anoikis. Oncogene (2015) 0.76
The tumor suppressor DiRas3 forms a complex with H-Ras and C-RAF proteins and regulates localization, dimerization, and kinase activity of C-RAF. J Biol Chem (2012) 0.75
HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature. Cell Stress Chaperones (2016) 0.75
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
ras genes. Annu Rev Biochem (1987) 22.59
Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33
ras oncogenes in human cancer: a review. Cancer Res (1989) 22.03
Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem (1994) 14.36
Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem (1998) 13.93
Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol (1994) 12.40
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell (1995) 11.86
Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature (1994) 10.34
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature (1999) 8.42
Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature (1999) 7.66
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell (1997) 6.55
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (1995) 6.35
Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol (1998) 6.27
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature (1994) 6.16
Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J (1997) 6.14
Increasing complexity of Ras signaling. Oncogene (1998) 5.71
Integrins and anoikis. Curr Opin Cell Biol (1997) 5.38
Multiple Ras functions can contribute to mammalian cell transformation. Cell (1995) 5.24
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol (1995) 4.78
Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci (1994) 4.38
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J (1996) 3.99
Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol (2000) 3.86
Ras effectors. Curr Opin Cell Biol (1996) 3.28
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev (1997) 3.23
A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (1994) 3.05
Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol Cell Biol (1989) 2.90
Integrins, oncogenes, and anchorage independence. J Cell Biol (1997) 2.86
Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem (1998) 2.75
Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol (1996) 2.69
The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell (1997) 2.57
Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J (1996) 2.44
Protein binding and signaling properties of RIN1 suggest a unique effector function. Proc Natl Acad Sci U S A (1997) 2.43
Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem (1999) 2.35
MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem (2000) 2.19
Biological assays for Ras transformation. Methods Enzymol (1995) 2.16
R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr Biol (1997) 1.98
rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol Cell Biol (1996) 1.86
Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J (1997) 1.69
Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dyn (1994) 1.64
Evidence for a Ras/Ral signaling cascade. Trends Biochem Sci (1996) 1.57
The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J (1999) 1.48
Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc Natl Acad Sci U S A (1996) 1.46
R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene (1994) 1.42
The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell (2000) 1.38
Characterization of an epithelioid cell line derived from rat small intestine: demonstration of cytokeratin filaments. Cell Biol Int Rep (1984) 1.38
Ras caught in another affair: the exchange factors for Ral. Curr Opin Genet Dev (1999) 1.32
Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J Cell Biol (2000) 1.27
An interleukin-1 beta-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett (1995) 1.26
Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr Biol (1998) 1.20
A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J Biol Chem (1997) 1.18
Differentiation and cancer in the mammary gland: shedding light on an old dichotomy. Adv Cancer Res (1998) 1.13
TC21 causes transformation by Raf-independent signaling pathways. Mol Cell Biol (1996) 1.03
A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis. J Biol Chem (1998) 1.02
Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J Immunol (1998) 0.95
Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade. Oncogene (1998) 0.95
R-Ras is regulated by activators and effectors distinct from those that control Ras function. Oncogene (1997) 0.91
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene (2007) 11.85
Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science (1997) 6.50
Increasing complexity of Ras signaling. Oncogene (1998) 5.71
Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci U S A (1982) 5.39
Biological and biochemical properties of human rasH genes mutated at codon 61. Cell (1986) 5.05
p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci U S A (1989) 4.80
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol (1995) 4.78
Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature (1997) 4.66
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science (1988) 4.58
GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J Cell Biol (1992) 4.34
Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol (2000) 3.86
Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (1997) 3.32
Rab1b regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments. J Cell Biol (1991) 3.22
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell (1989) 3.12
Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol Cell Biol (1997) 3.09
BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell (1993) 2.92
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell (2001) 2.89
Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol (1996) 2.69
The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem (1996) 2.60
Increasing complexity of the Ras signaling pathway. J Biol Chem (1998) 2.56
Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol (1995) 2.56
Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem (1997) 2.55
The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol (2000) 2.38
Critical role of Rho in cell transformation by oncogenic Ras. Oncogene (1995) 2.37
Dbl family proteins. Biochim Biophys Acta (1997) 2.36
Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas. Cell (1983) 2.27
The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J (1997) 2.19
Biological assays for Ras transformation. Methods Enzymol (1995) 2.16
Human cell hybrids: analysis of transformation and tumorigenicity. Science (1982) 2.16
The Ras signal transduction pathway. Cancer Metastasis Rev (1994) 2.13
Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci U S A (1992) 2.10
Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal. Science (1989) 2.04
Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene (1998) 1.99
Isoprenoid modification of rab proteins terminating in CC or CXC motifs. Proc Natl Acad Sci U S A (1991) 1.99
The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J Biol Chem (1997) 1.98
Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol (1997) 1.96
GTP binding by class II transactivator: role in nuclear import. Science (1999) 1.94
Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem (2000) 1.93
Two distinct Raf domains mediate interaction with Ras. J Biol Chem (1995) 1.88
Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci U S A (1990) 1.84
Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem (1999) 1.82
Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21. Cell (1984) 1.76
Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat (1995) 1.75
Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem (1995) 1.75
rasH mutants deficient in GTP binding. Mol Cell Biol (1986) 1.73
Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc Natl Acad Sci U S A (1994) 1.67
The six amino-terminal amino acids of p60src are sufficient to cause myristylation of p21v-ras. Mol Cell Biol (1988) 1.65
Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol (1994) 1.60
ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun. Mol Cell Biol (1989) 1.59
Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins. Bioessays (1995) 1.57
Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J (1993) 1.56
Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol (1998) 1.55
Protein prenylation: more than just glue? Curr Opin Cell Biol (1992) 1.54
Splice variants of intersectin are components of the endocytic machinery in neurons and nonneuronal cells. J Biol Chem (1999) 1.53
The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein. Mol Cell Biol (1991) 1.52
Biological assays for cellular transformation. Methods Enzymol (1994) 1.51
Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras [corrected]. J Biol Chem (1996) 1.50
Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene (1994) 1.48
Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med (2001) 1.46
Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc Natl Acad Sci U S A (1996) 1.46
Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett (2001) 1.45
RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem (2001) 1.44
Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity. Proc Natl Acad Sci U S A (1994) 1.44
Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J Immunol (1991) 1.43
R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene (1994) 1.42
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? Biochim Biophys Acta (1997) 1.42
Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation. J Biol Chem (1996) 1.42
Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem (1996) 1.39
Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein. Mol Cell Biol (1992) 1.39
Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J Biol Chem (1994) 1.39
Molecular basis for Rac1 recognition by guanine nucleotide exchange factors. Nat Struct Biol (2001) 1.39
Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA. J Biol Chem (2001) 1.39
Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation. Mol Cell Biol (1999) 1.38
Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J Biol Chem (1999) 1.38
Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev (2009) 1.36
Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling. J Biol Chem (1996) 1.32
M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J Biol Chem (1999) 1.30
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene (2001) 1.29
R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J Cell Biol (1995) 1.29
Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. Oncogene (1996) 1.25
Quantitative analysis of the effect of phosphoinositide interactions on the function of Dbl family proteins. J Biol Chem (2001) 1.22
Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor. Oncogene (1994) 1.22
Identification of residues critical for Ras(17N) growth-inhibitory phenotype and for Ras interaction with guanine nucleotide exchange factors. Mol Cell Biol (1994) 1.21
Ras (CXXX) and Rab (CC/CXC) prenylation signal sequences are unique and functionally distinct. J Biol Chem (1992) 1.20
Novel determinants of H-Ras plasma membrane localization and transformation. Oncogene (1996) 1.20
Protein prenylation: key to ras function and cancer intervention? Cell Growth Differ (1992) 1.20
Activation of phospholipase C-epsilon by heterotrimeric G protein betagamma-subunits. J Biol Chem (2001) 1.19
A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J Biol Chem (1997) 1.18
14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain. J Biol Chem (1997) 1.17
Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. Curr Biol (1999) 1.17
Biological and structural characterization of a Ras transforming mutation at the phenylalanine-156 residue, which is conserved in all members of the Ras superfamily. Proc Natl Acad Sci U S A (1995) 1.16
Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. Proc Natl Acad Sci U S A (1986) 1.16
Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling. Oncogene (2009) 1.14
Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions. J Biol Chem (2000) 1.14